World's First Self-Amplifying RNA (saRNA) Vaccine for COVID-19 Approved in Japan, But China Has Yet to Approve It Despite the Virus Being Discovered in Wuhan, China
In a groundbreaking move, Japan has recently granted approval for the world's first 'self-amplifying' RNA (saRNA) vaccine, ARCT-154, in the fight against Covid-19, marking a significant leap in vaccine technology with potential applications against various infectious diseases and cancer.